![Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab - Sally Thirkettle, Joanne Russell, Sarah Wilson, Tasneem Ganijee, Samar Kulkarni, Jim Cavet, Phillip J Monaghan, Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab - Sally Thirkettle, Joanne Russell, Sarah Wilson, Tasneem Ganijee, Samar Kulkarni, Jim Cavet, Phillip J Monaghan,](https://journals.sagepub.com/cms/10.1177/0004563219894354/asset/images/large/10.1177_0004563219894354-fig1.jpeg)
Implications for the monitoring of patients with multiple myeloma undergoing treatment with the anti-CD38 monoclonal daratumumab - Sally Thirkettle, Joanne Russell, Sarah Wilson, Tasneem Ganijee, Samar Kulkarni, Jim Cavet, Phillip J Monaghan,
![Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study - Roy Vitkon, Dan Netanely, Shai Levi, Tomer Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study - Roy Vitkon, Dan Netanely, Shai Levi, Tomer](https://journals.sagepub.com/cms/10.1177/20406207211035272/asset/images/large/10.1177_20406207211035272-fig2.jpeg)
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study - Roy Vitkon, Dan Netanely, Shai Levi, Tomer
![Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference](https://www.degruyter.com/document/doi/10.1515/cclm-2021-0399/asset/graphic/j_cclm-2021-0399_fig_001.jpg)
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
![IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases](https://www.mdpi.com/ijms/ijms-24-09531/article_deploy/html/images/ijms-24-09531-g001.png)
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
![Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma | Bone Marrow Transplantation Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bmt.1702850/MediaObjects/41409_2001_Article_BF1702850_Fig1_HTML.jpg)
Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma | Bone Marrow Transplantation
![Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance](https://www.mdpi.com/cancers/cancers-13-05131/article_deploy/html/images/cancers-13-05131-g001.png)
Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
![Cells | Free Full-Text | The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation Cells | Free Full-Text | The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation](https://pub.mdpi-res.com/cells/cells-09-00842/article_deploy/html/images/cells-09-00842-g001.png?1588934607)
Cells | Free Full-Text | The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
![A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation | Neurology Neuroimmunology & Neuroinflammation A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation | Neurology Neuroimmunology & Neuroinflammation](https://www.neurology.org/cms/10.1212/NXI.0000000000000888/asset/cca73d06-5d7b-42ee-8b7e-2c7cca2c0f67/assets/graphic/nxi.0000000000000888f1.jpeg)
A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation | Neurology Neuroimmunology & Neuroinflammation
![Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance](https://pub.mdpi-res.com/cancers/cancers-13-05131/article_deploy/html/images/cancers-13-05131-g002.png?1634285635)
Cancers | Free Full-Text | Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
![Immunoelectrophoresis ofproducts released after treatment ofIgG-bearing... | Download Scientific Diagram Immunoelectrophoresis ofproducts released after treatment ofIgG-bearing... | Download Scientific Diagram](https://www.researchgate.net/publication/16394789/figure/fig1/AS:601695528693773@1520466801340/Immunoelectrophoresis-ofproducts-released-after-treatment-ofIgG-bearing-liposomes-with.png)
Immunoelectrophoresis ofproducts released after treatment ofIgG-bearing... | Download Scientific Diagram
![Diagnostics | Free Full-Text | Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment Diagnostics | Free Full-Text | Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment](https://www.mdpi.com/diagnostics/diagnostics-12-00720/article_deploy/html/images/diagnostics-12-00720-g001.png)